TACROLIMUS INDUCED TREMORS AMONG POST RENAL TRANSPLANT PATIENTS: A CASE SERIES
Keywords:Tacrolimus, Tremors, Neurological complications, Renal transplant, Triple immunosuppression
Triple immunosuppression in renal transplant has drastically changed the outcome of graft survival. However, concern always remains among the
physicians because of adverse effects produced due to triple immunosuppression. Calcineurin inhibitors are associated with wide range of side effects. Hence, we report a case series of tremors associated with tacrolimus among renal transplant patients in a tertiary care hospital in southern India.
Patel DD, Modi KP, Patel AK, Chaudhary V. New onset of diabetes mellitus in Indian renal transplant recipient - A retrospective study. Int J Pharm Pharm Sci 2015;7(11):228-32.
Patel S, Patel BG, Gohel K. Incidences of-and risk factor for new onset diabetes after transplantation in live donor kidney transplantation: A prospective single centre study. Int J Pharm Pharm Sci 2106;8(2):230-3.
Chegounchi M, Hanna MG, Neild GH. Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation. BMC Nephrol 2006;7:7.
Parvex P, Pinsk M, Bell LE, Oâ€™Gorman AM, Patenaude YG, Gupta IR. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 2001;16(7):537-42.
Grimbert P, Azema C, Pastural M, Dhamane D, Remy P, Salomon L, et al. Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. Nephrol Dial Transplant 1999;14(10):2489-91.
Yoon T, Kelly BM, Hornyak J. Use of propranolol for treating tacrolimus-induced tremors: A case report. Arch Phys Med Rehabil 2007;88(9):E19.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45.
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49(9):2229-32.
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27(6):538.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.